Clinical Trial Update: Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR [NA]

View source ↗

Summary

This entry describes an ongoing clinical trial evaluating the safety and effectiveness of a 532 nm laser subthreshold panretinal photocoagulation for severe non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• 532 nm laser subthreshold panretinal photocoagulation

Snippet

Sponsor: Sun Yat-sen University | Conditions: Severe Non-proliferative Diabetic Retinopathy | NA | Status: UNKNOWN